MitoDys Therapeutics ltd

Big Data and informatics-derived multi-targeted drugs as disease modifying agents for neurodegenerative diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Oxford, United Kingdom
  • Currency GBP
  • Founded September 2012
  • Employees 4
  • Incorporation Type Other
  • Website mitodys.com

Company Summary

Mitodys is a capital-efficient drug discovery start-up focused on uncovering proprietary drugs with profiles that allow them to be repositioned to a new indication. Its focus is on the discovery of disease-modifying agents for the treatment of neurodegenerative diseases using a systems-targeted approach which represents a new paradigm in drug discovery. The diseases targeted remain poorly- or unmet needs valued in the billions of US dollars.

Team

  • Steven Zimmer
    Founder and CEO

    Trained Scientist (Biochemistry, Molecular Biology and Genetics) and ex-Wall Street and City (F.Eberstadt, Flemings, DLJ and CSFB). Co-founder of companies (Orthomatrix, Steribottle, Tissuomics and Protein Sciences) and consulted for various companies (Ascom, e-Therapeutics and Selventa amongst others)

  • Simon Bennett
    Director and Business Development

    DPhil in Human genetics and former Wellcome Trust Research fellow who is a highy experienced Biotech executive having worked for Oxagen, Solexa and Glide Pharma. Consultant to Menarini Biotech and Director of colwiz

  • Steven Zimmer

  • Andrew Wood
    CFO

    CFO of Oxford Biomedica for 17 years. BSc in Biochemistry from Oxford University and ACA.

  • Simon Smith
    Director and Chief Legal Advisor

    Trained business lawyer who runs a technology and biotech law practice in Oxford UK

Advisors

  • Simon Smith/Taveners
    Lawyer
    Unconfirmed
    James Cowper
    Accountant
    Unconfirmed

Previous Investors

  • The Life Neurological Research Trust
    Trustee
    Unconfirmed
    Alex Gerko
    Unconfirmed
    Dmitry Shakin
    Quant Trader
  • Juliet Telford
    Private Investor
    Unconfirmed
    Camilla Georgiou
    Trustee

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free